TScan Therapeutics TCRX
NASDAQ TCRX
$0.14 -0.01 (-6.67%)
At close: Nov 19, 2026 · 4:00 PM EST

TScan Therapeutics (TCRX) Change in Accrued Expenses (2020 - 2026)

Updated

TScan Therapeutics (TCRX) reported Change in Accrued Expenses of $5.04 million for Q3 2026, compared with -$1.11 million a year earlier.

Analysis

TScan Therapeutics (TCRX) Change in Accrued Expenses (2020 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, TScan Therapeutics' Change in Accrued Expenses came in at $1.83 million; for FY2025, it came in at -$7.23 million.

  • By year, Change in Accrued Expenses came in at $4.53 million in FY2024 (+17.6%), $3.85 million in FY2023 (+426.4%), $732,000 in FY2022 (-77.4%) and $3.23 million in FY2021 (+108.6%).
  • The Q3 2026 figure ranks as the highest quarterly Change in Accrued Expenses in data going back to Q3 2020.
  • The high point for year-over-year Change in Accrued Expenses in five years was Q4 2024 (growth of 179.3%); the low point was Q3 2024 (a decline of 48.4%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at -$740,000 (Q2 2026), $904,000 (Q1 2026) and -$3.38 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 397,968.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn -
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 2.41 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 983.00 Mn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn -
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 756.00 Mn
9 Gsk 193.54 Bn 176.38 Bn - -
10 TScan Therapeutics 18.87 Mn -434.83 Mn - 5.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 5.04 Mn
Jun 30, 2026 -740,000.00
Mar 31, 2026 904,000.00
Dec 31, 2025 -3.38 Mn
Sep 30, 2025 -1.11 Mn
Jun 30, 2025 2.67 Mn
Mar 31, 2025 -5.41 Mn
Dec 31, 2024 3.66 Mn
Sep 30, 2024 527,000.00
Jun 30, 2024 1.95 Mn
Mar 31, 2024 -1.60 Mn
Dec 31, 2023 1.31 Mn
Sep 30, 2023 1.02 Mn
Jun 30, 2023 783,000.00
Mar 31, 2023 737,000.00
Dec 31, 2022 1.32 Mn
Sep 30, 2022 1.60 Mn
Jun 30, 2022 609,000.00
Mar 31, 2022 -2.80 Mn
Dec 31, 2021 1.85 Mn
API Access

TScan Therapeutics Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=TCRX&period=max&api_key=YOUR_API_KEY